{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T05:57:40Z","timestamp":1716271060126},"reference-count":16,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2017.5364","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T09:46:10Z","timestamp":1508838370000},"source":"Crossref","is-referenced-by-count":4,"title":["Monitoring of peripheral blood cluster of differentiation 4+ adenosine triphosphate activity and CYP3A5 genotype to determine the pharmacokinetics, clinical effects and complications of tacrolimus in patients with autoimmune diseases"],"prefix":"10.3892","author":[{"given":"Yuichi","family":"Muraki","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Mie University Hospital, Tsu, Mie 514\u20118507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shugo","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Transplantation and Hepatobiliary Pancreatic Surgery, Mie University Graduate School of Medicine, Tsu, Mie 514\u20118507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaname","family":"Nakatani","sequence":"additional","affiliation":[{"name":"Department of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine, Tsu, Mie 514\u20118507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Wakabayashi","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Tsu, Mie 514\u20118507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji\u00ef\u00bf\u00bd","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Mie 514\u20118507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimitsu","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal and Pediatric Surgery, Mie University Graduate School of Medicine, Tsu, Mie 514\u20118507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mie University Graduate School of Medicine, Tsu, Mie 514\u20118507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Isaji","sequence":"additional","affiliation":[{"name":"Department of Transplantation and Hepatobiliary Pancreatic Surgery, Mie University Graduate School of Medicine, Tsu, Mie 514\u20118507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Okuda","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Mie University Hospital, Tsu, Mie 514\u20118507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"key":"key20200713143218_b1-etm-0-0-5364","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1034\/j.1399-0012.2003.00013.x","article-title":"Immune cell function testing: An adjunct to therapeutic drug monitoring in transplant patient management","volume":"17","author":"Kowalski","year":"2003","journal-title":"Clin Transplant"},{"key":"key20200713143218_b2-etm-0-0-5364","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s00534-010-0335-8","article-title":"Monitoring peripheral blood CD4+ adenosine triphosphate activity after living donor liver transplantation: Impact of combination assays of immune function and CYP3A5 genotype","volume":"18","author":"Mizuno","year":"2011","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"key20200713143218_b3-etm-0-0-5364","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/01.tp.0000234837.02126.70","article-title":"Assessing relative risks of infection and rejection: A meta-analysis using an immune function assay","volume":"82","author":"Kowalski","year":"2006","journal-title":"Transplantation"},{"key":"key20200713143218_b4-etm-0-0-5364","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.trim.2007.03.005","article-title":"Preceeding the rejection: In search for a comprehensive post-transplant immune monitoring platform","volume":"18","author":"Israeli","year":"2007","journal-title":"Transpl Immunol"},{"key":"key20200713143218_b5-etm-0-0-5364","doi-asserted-by":"publisher","first-page":"55","DOI":"10.12659\/AOT.882219","article-title":"Impact of CYP3A5 genotype of recipients as well as donors on the tacrolimus pharmacokinetics and infectious complications after living-donor liver transplantation for Japanese adult recipients","volume":"16","author":"Muraki","year":"2011","journal-title":"Ann Transplant"},{"key":"key20200713143218_b6-etm-0-0-5364","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.3748\/wjg.v21.i6.1880","article-title":"Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis","volume":"21","author":"Kawakami","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20200713143218_b7-etm-0-0-5364","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2169\/internalmedicine.47.0513","article-title":"Long-term treatment of steroid-dependent myasthenia gravis patients with low-dose tacrolimus","volume":"47","author":"Nagaishi","year":"2008","journal-title":"Intern Med"},{"key":"key20200713143218_b8-etm-0-0-5364","unstructured":"The US Food and Drug AdministrationClass II Special Controls Guidance Document: cyclosporine and tacrolimus assays; guidance for industry and FDA2002http:\/\/www.fda.gov\/MedicalDevices\/DeviceRegulationandGuidance\/GuidanceDocuments\/ucm092778.htm"},{"key":"key20200713143218_b9-etm-0-0-5364","doi-asserted-by":"publisher","first-page":"936063","DOI":"10.1155\/2013\/936063","article-title":"Immune response following liver transplantation compared to kidney transplantation: Usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity and cytochrome P450 3A5 genotype assay","volume":"2013","author":"Nobuoka","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"key20200713143218_b10-etm-0-0-5364","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5527\/wjn.v1.i6.177","article-title":"Treatment of young patients with lupus nephritis using calcineurin inhibitors","volume":"1","author":"Tanaka","year":"2012","journal-title":"World J Nephrol"},{"key":"key20200713143218_b11-etm-0-0-5364","doi-asserted-by":"publisher","first-page":"c330","DOI":"10.1159\/000235952","article-title":"Clinical assessment of tacrolimus therapy in lupus nephritis: One-year follow-up study in a single center","volume":"113","author":"Asamiya","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"key20200713143218_b12-etm-0-0-5364","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/00008571-200206000-00009","article-title":"Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese population","volume":"12","author":"Fukuen","year":"2002","journal-title":"Pharmacogenetics"},{"key":"key20200713143218_b13-etm-0-0-5364","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0140-6736(98)07493-5","article-title":"Immunosuppressive strategies in transplantation","volume":"353","author":"Denton","year":"1999","journal-title":"Lancet"},{"key":"key20200713143218_b14-etm-0-0-5364","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/86882","article-title":"Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression","volume":"27","author":"Kuehl","year":"2001","journal-title":"Nat Genet"},{"key":"key20200713143218_b15-etm-0-0-5364","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/01.fpc.0000184953.31324.e4","article-title":"Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients","volume":"16","author":"Uesugi","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"key20200713143218_b16-etm-0-0-5364","doi-asserted-by":"publisher","first-page":"982163","DOI":"10.1155\/2013\/982163","article-title":"Immunological aspects in late phase of living donor liver transplant patients: Usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity","volume":"2013","author":"Mizuno","year":"2013","journal-title":"Clin Dev Immunol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T13:38:57Z","timestamp":1594647537000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2017.5364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":16,"URL":"https:\/\/doi.org\/10.3892\/etm.2017.5364","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,24]]}}}